There are 119 resources available
42P - BAL0891: a novel, small molecule, dual TTK/PLK1 mitotic checkpoint inhibitor (MCI) with potent single agent activity
Presenter: Heidi Lane
Session: e-Poster Display session
51P - Mitochondrial Pro-Apoptotic Properties of isolated compounds from two soft corals of Persian Gulf
Presenter: afsaneh yegdaneh
Session: e-Poster Display session
53P - Assessing the reporting quality of early phase dose-finding trials
Presenter: Christina Yap
Session: e-Poster Display session
54P - Targeted treatment options for childhood hepatoblastoma using high-throughput drug screening
Presenter: Ruth Nousiainen
Session: e-Poster Display session
55P - Potential benefits of extensive genomic analysis in patients with KRAS mutated solid tumors; concurrent alterations and potential targets
Presenter: Ida Jacobsen
Session: e-Poster Display session
56P - An Institutional study evaluating the benefit of blood NGS over conventional hotspot molecular genetic testing in metastatic adenocarcinoma lung.
Presenter: Rajashree ashwath
Session: e-Poster Display session
12P - Circulating tumor DNA as early marker of response to treatment in stage IV gastrointestinal cancer
Presenter: Patrick Kirchweger
Session: e-Poster Display session
14P - A novel small molecule METTL3 inhibitor exerts promising antitumor effects on oral squamous cell carcinoma
Presenter: Paramasivam Arumugam
Session: e-Poster Display session
15P - STELLAR-001: a phase 1 study of the anti-C5aR avdoralimab in combination with the anti-PD-L1 durvalumab in advanced solid tumors.
Presenter: Jaafar Bennouna
Session: e-Poster Display session
16P - Checkpoint modification of BTLA-HVEM-LIGHT signaling by HSV-1 glycoprotein D (gD) improves vaccine-induced CD8+ T cell responses in pre-clinical cancer models
Presenter: Hildegund Ertl
Session: e-Poster Display session